WARREN JOHNSON: Open Payments
NPI 1134168925 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,458 in 139 payments from 30 companies in 2025. Trend: 2023 $2,166 · 2024 $2,597 · 2025 $2,458
Food & beverage: $2,458
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $478 |
| ABBVIE INC. | 37 | $346 |
| PFIZER INC. | 9 | $184 |
| Novo Nordisk Inc | 13 | $178 |
| Lilly USA, LLC | 6 | $126 |
| Abbott Laboratories | 5 | $118 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $107 |
| Dexcom, Inc. | 4 | $80 |
| Astellas Pharma US Inc | 3 | $69 |
| Amgen Inc. | 4 | $69 |
Products named: BREZTRI, VRAYLAR, JARDIANCE, Ozempic, AIRSUPRA, UBRELVY, ELIQUIS, XIFAXAN.
Industry payments across AZ — which companies pay providers there.
